Table 3 Obstetrical outcome among BV patients after treatment with clindamycin
Obstetric outcome | BV | No BV | Missing | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Effect of treatment | Yes | All BV | % | Yes | All No BV | % | Total | |||
Instrument delivery | 64 | 816 | 7.8 | 631 | 7945 | 7.9 | 30 | OR 1.0 (95% CI 0.8–1.3) | 8791 | |
Treated BV vs. not treated BV | 34 | 407 | 8.4 | OR 0.9 (95% CI 0.6–1.3) | 816 | |||||
Cesarean delivery | 107 | 816 | 13.1 | 1124 | 7945 | 14.1 | 30 | OR 0.9 (95% CI 0.7–1.1) | 8791 | |
Treated BV vs. not treated BV | 52 | 407 | 12.8 | OR 0.9 (95% CI 0.7–1.3) | 816 | |||||
Preeclampsia | 36 | 816 | 4.4 | 304 | 7945 | 3.8 | 30 | OR 1.2 (95% CI 0.8–1.7) | 8791 | |
Treated BV vs. not treated BV | 17 | 407 | 4.2 | OR 1.2 (95% CI 0.7–1.9) | 816 | |||||
Early rupture of membranes | 43 | 816 | 5.3 | 391 | 7945 | 4.9 | 30 | OR 1.1 (95% CI 0.8–1.5) | 8791 | |
Treated BV vs. not treated BV | 24 | 407 | 5.9 | OR 0.9 (95% CI 0.6–1.5) | 816 | |||||
SGA | 49 | 815 | 6.0 | 374 | 7920 | 4.7 | 56 | OR 1.3 (95% CI 0.95–1.8) | 8791 | |
Treated BV vs. not treated BV | 21 | 407 | 5.2 | OR 1.4 (95% CI 0.98–2.2) | 815 | |||||
5 min. | 22 | 819 | 2.7 | 191 | 7972 | 2.4 | 0 | OR 1.1 (95% CI 0.7–1.8) | 8791 | |
Treated BV vs. not treated BV | 7 | 407 | 1.7 | OR 1.5 (95% CI 0.9–2.6) | 819 | |||||
Gender = Female | 379 | 815 | 46.5 | 3846 | 7933 | 48.5 | 43 | OR 0.9 (95% CI 0.8–1.1) | 8791 | |